Function of PTEN during the formation and maintenance of neuronal circuits in the brain

Developmental Neuroscience

Volumn 30, Issue 1-3, 2007, Pages 59-64

  Van Diepen, Michiel T ^a   Eickholt, Britta J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Knockout mice; Neuronal circuits; PI3K signaling; PTEN

Indexed keywords

EN2 PROTEIN; GFAP PROTEIN; L7 PROTEIN; NESTIN; NSE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; SRC HOMOLOGY 2 CONTAINING INOSITOL 5' PHOSPHATASE; UNCLASSIFIED DRUG;

BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL MIGRATION; CELL MOTILITY; DEPHOSPHORYLATION; GENE; GENE MUTATION; GLIOBLASTOMA; HUMAN; KNOCKOUT MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NONHUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE GENE; PHOSPHORYLATION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL PATHWAYS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 37149046442     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109852     Document Type: Short Survey

References (41)

1. Yoshimura T, Arimura N, Kaibuchi K: Signaling networks in neuronal polarization. J Neurosci 2006;26:10626-10630.
2. Goold RG, Gordon-Weeks PR: The MAP kinase pathway is upstream of the activation of GSK3beta that enables it to phosphorylate MAP1B and contributes to the stimulation of axon growth. Mol Cell Neurosci 2005;28:524-534.
3. Shaw RJ, Cantley LC: Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006;441:424-430.
4. Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T: Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta. J Biol Chem 2005;280:35195-35202.
5. Leslie NR, Downes CP: PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004;382:1-11.
6. Sulis ML, Parsons R: PTEN: from pathology to biology. Trends Cell Biol 2003;13:478-483.
7. Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM: Structure, function, and biology of SHIP proteins. Genes Dev 2000;14:505-520.
8. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M: Control of dendritic arborization by the phosphoinositide-3́-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 2005;25:11300-11312.
9. Jiang H, Guo W, Liang X, Rao Y: Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 2005;120:123-135.
10. Ning K, Miller LC, Laidlaw HA, Burgess LA, Perera NM, Downes CP, Leslie NR, Ashford ML: A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells. EMBO J 2006;25:2377-2387.
11. Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA, Jones GE, Eickholt BJ: PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci 2006;119:951-957.
12. Arevalo MA, Rodriguez-Tebar A: Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth. Mol Biol Cell 2006;17:3369-3377.
13. Maehama T, Dixon JE: PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 1999;9:125-128.
14. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998;280:1614-1617.
15. Mahimainathan L, Choudhury GG: Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 2004;279:15258-15268.
16. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004;303:1179-1181.
17. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nat Genet 1998;19:348-355.
18. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998;8:1169-1178.
19. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X, Wu H: Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 2001;294:2186-2189.
20. Marino S, Krimpenfort P, Leung C, van der Korput HA, Trapman J, Camenisch I, Berns A, Brandner S: PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 2002;129:3513-3522.
21. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ: Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 2001;29:404-411.
22. Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X: PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 2005;132:3281-3291.
23. Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ: Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 2004;64:7773-7779.
24. Backman SA, Stambolic V, Suzuki A, Haight J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO, Mak TW: Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 2001;29:396-403.
25. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF: Pten regulates neuronal arborization and social interaction in mice. Neuron 2006;50:377-388.
26. Lopez-Sanchez E, Frances-Munoz E, Menezo JL, Pinazo-Duran MD: Optic nerve alterations in PTEN+/- mice. Eur J Ophthalmol 2006;16:440-445.
27. Kwon CH, Zhu X, Zhang J, Baker SJ: mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci USA 2003;100:12923-12928.
28. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC: Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998;17:6649-6659.
29. Chalhoub N, Kozma SC, Baker SJ: S6k1 is not required for Pten-deficient neuronal hypertrophy. Brain Res 2006;1100:32-41.
30. Rice DS, Curran T: Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 2001;24:1005-1039.
31. Polleux F, Whitford KL, Dijkhuizen PA, Vitalis T, Ghosh A: Control of cortical interneuron migration by neurotrophins and PI3-kinase signaling. Development 2002;129:3147-3160.
32. Sakakibara A, Horwitz AF: Mechanism of polarized protrusion formation on neuronal precursors migrating in the developing chicken cerebellum. J Cell Sci 2006;119:3583-3592.
33. Shi SH, Jan LY, Jan YN: Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell 2003;112:63-75.
34. Menager C, Arimura N, Fukata Y, Kaibuchi K: PIP3 is involved in neuronal polarization and axon formation. J Neurochem 2004;89:109-118.
35. Kumar V, Zhang MX, Swank MW, Kunz J, Wu GY: Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 2005;25:11288-11299.
36. Cole AR, Causeret F, Yadirgi G, Hastie CJ, McLauchlan H, McManus EJ, Hernandez F, Eickholt BJ, Nikolic M, Sutherland C: Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem 2006;281:16591-16598.
37. Yoshimura T, Arimura N, Kawano Y, Kawabata S, Wang S, Kaibuchi K: Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway. Biochem Biophys Res Commun 2006;340:62-68.
38. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K: GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005;120:137-149.
39. Ito Y, Oinuma I, Katoh H, Kaibuchi K, Negishi M: Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep 2006;7:704-709.
40. Eickholt BJ, Walsh FS, Doherty P: An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol 2002;157:211-217.
41. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C: Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005;42:318-321.